Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Phospho-AP2M1 (Thr156) Antibody (R2L42)

Catalog #:   RHJ96501 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: WB
Accession: Q96CW1
Overview

Catalog No.

RHJ96501

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

WB: 1:500-1:1000

Target

Adaptor-related protein complex 2 subunit mu, AP-2 mu chain, CLAPM1, HA2 50 kDa subunit, Plasma membrane adaptor AP-2 50 kDa protein, Adaptin-mu2, AP2M1, KIAA0109, Clathrin coat assembly protein AP50, Adaptor protein complex AP-2 subunit mu, Clathrin assembly protein complex 2 mu medium chain, AP-2 complex subunit mu, Clathrin coat-associated protein AP50

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q96CW1

Applications

WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2L42

Data Image
References

Pathophysiological mechanisms of hair follicle regeneration and potential therapeutic strategies., PMID:40518544

Advances in platinum-based cancer therapy: overcoming platinum resistance through rational combinatorial strategies., PMID:40518502

Age-independent anti-angiogenic therapy for choroidal neovascularization by targeting secretogranin III., PMID:40518488

High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors., PMID:40518465

Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma., PMID:40518441

Tildrakizumab 200 mg: a step forward in psoriasis treatment with added metabolic benefits., PMID:40518438

[Analysis of inhalant and food allergen-specific IgE in a children's hosipital in Suzhou City from 2017 to 2024]., PMID:40518417

[Analysis of sensitization characteristics and changing trends of common allergens in a children's hospital in Shanghai City from 2020 to 2024]., PMID:40518416

[Analysis of the clinical efficacy and safety of dupilumab in the treatment of patients with moderate to severe atopic dermatitis complicated with asthma]., PMID:40518414

[Advances in the evaluation and prediction of the efficacy of allergen-specific immunotherapy]., PMID:40518411

Retreatment With Anti-CD38-Based Combinations in Multiple Myeloma in Real-Life: Results From the Emmy Cohort Study., PMID:40518372

Highly sensitive nanobody-immunosensor for macrophage-capping protein., PMID:40518371

Development of Thyrotoxicosis With Positive TSH Receptor Antibody and Transition to Hypothyroidism in a Patient With Unresectable Hepatocellular Carcinoma During Combined Atezolizumab and Bevacizumab Therapy: A Case Report and Review of the Literature., PMID:40518311

[Pharmacological characteristics of tisotumab vedotin (recombinant) (TIVDAK® 40 ‍mg Intravenous Solution) and clinical study results in recurrent or metastatic cervical cancer]., PMID:40518306

Purification of Recombinant Monoclonal Antibodies from Transgenic Chicken Eggs and Removal of Egg-White Proteins., PMID:40518304

Advancing hepatobiliary diagnosis and treatment using shortwave-infrared fluorescence imaging with ICG-C9., PMID:40518281

Seroprevalence of Neospora caninum infection in cattle and yaks in the northern mountainous regions of Kyrgyzstan., PMID:40518251

Investigation of Schmallenberg virus and update on the serological status of Toxoplasma gondii in goat herds in the semiarid region of Pernambuco state, Brazil., PMID:40518245

Precision medicine approaches to CNS metastatic disease., PMID:40518193

[Clinical analysis of 4 cases of juvenile dermatomyositis complicated with massive hemorrhage of digestive tract]., PMID:40518160

Molecular chaperones: A revolutionary approach for increased solubility of recombinant mAbs from bacterial and yeast systems., PMID:40518128

Characteristics of Kawasaki disease in children with a history of COVID-19., PMID:40517900

Journal of Oral Biosciences Proteolytic N-terminal processing of Mfa proteins in the periodontal pathogen Porphyromonas gingivalis., PMID:40517809

Engineered MAP30ER: A plant toxin-derived platform for EGFR-Targeted delivery of protein and chemotherapeutic payloads., PMID:40517671

Rapid detection of duck egg ovalbumin (D-OVA) in surimi via fluorescent immunochromatographic assay utilizing shark-derived single-domain antibody., PMID:40517652

Interlaboratory study to assess precision and reproducibility of the meningococcal antigen surface expression (MEASURE) assay to quantify factor H binding protein expression at the surface of meningococcal serogroup B strains., PMID:40517645

Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial., PMID:40517603

Evolution of TROP2: Biological insights and clinical applications., PMID:40517574

Marginal Zone Lymphoma: Treatment Update With a Focus on Systemic Approaches., PMID:40517548

Multiple Myeloma Unpacked., PMID:40517540

Incident COVID-19 infections before Omicron in the U.S., PMID:40517531

Follicular Lymphoma: Current Therapeutic Landscape and Future Prospects., PMID:40517443

Advances in the Management of Relapsed/Refractory CLL and Richter Transformation., PMID:40517442

T-Cell Redirecting Strategies in Large B-Cell Lymphoma and Follicular Lymphoma., PMID:40517438

A Phase 2 Study of Obinutuzumab Combined with Lenalidomide in Previously Untreated High Tumor Burden Follicular Lymphoma., PMID:40517417

Cas9- and Cas12a-mediated excision and replacement of the celiac disease-related α-gliadin immunogenic complex in hexaploid wheat., PMID:40517395

Investigation of the Efficacy and Safety of Xeligekimab (GR1501) in Patients with Moderate-to-Severe Plaque Psoriasis: A Multicenter, Randomized, Double-Blind Phase II Clinical., PMID:40517362

Assessment of Lyme Seroconversion Among US Military Personnel in Honduras., PMID:40517326

Therapeutic Effect of Galactosyltransferase- and Sialyltransferase-encoding mRNA in Rheumatoid Arthritis., PMID:40517291

Positive coactivator PC4 shows dynamic nucleolar distribution required for rDNA transcription and protein synthesis., PMID:40517275

Quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric MRI., PMID:40517176

Doubling multiplexed imaging capability via spatial expression pattern-guided protein pairing and computational unmixing., PMID:40517167

Advances in molecular pathology and therapy of non-small cell lung cancer., PMID:40517166

Enhanced visualization of colonic polyps using a fluorophore-conjugated claudin-1 antibody in a CPC-APC mouse model., PMID:40517099

Evaluating the Role of CAR-T Cell Therapy in the Context of Current Therapy Options for Patients With Relapsed or Refractory Follicular Lymphoma., PMID:40516919

The Role of Tumor Microenvironment and Immune Cell Crosstalk in Triple-Negative Breast Cancer (TNBC): Emerging Therapeutic Opportunities., PMID:40516902

Potential blocker of SARS-CoV entry and a narrow functionality of its spike protein motifs on Qubevirus platform., PMID:40516871

Nanobodies targeting EGFR provide insight into conformations stabilized by glioblastoma mutations., PMID:40516870

A pooled analysis of datopotamab deruxtecan in patients with EGFR-mutated NSCLC., PMID:40516821

Genomic profiles of pathogenic and moderate-penetrance germline variants associated with risk of early-onset lung adenocarcinoma., PMID:40516820

Datasheet
$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Phospho-AP2M1 (Thr156) Antibody (R2L42) [RHJ96501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only